CRISPR Therapeutics AG (CRSP) Interest & Investment Income (2020 - 2026)
CRISPR Therapeutics AG (CRSP) reported Interest & Investment Income of -$6.7 million for Q1 2026, down 398.58% on a YoY basis from $2.3 million in Q1 2025, and down 3954.22% sequentially from -$166000.0 in Q4 2025.
CRISPR Therapeutics AG (CRSP) Interest & Investment Income (2020 - 2026) Analysis & Trends
CRISPR Therapeutics AG (CRSP) has 7 years of Interest & Investment Income data on file, last reported at -$6.7 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 398.58% year-over-year to -$6.7 million; the trailing twelve-month figure through Mar 2026 stood at -$6.1 million (down 207.82% YoY), and the FY2025 full-year result was $2.9 million, up 5650.0% from the prior year.
- Interest & Investment Income eased to -$6.7 million in Q1 2026, from -$166000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $13.4 million in Q3 2024 to a low of -$11.8 million in Q1 2022.
- A 5-year average of $182000.0 and a median of -$166000.0 in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income tumbled 2980.68% in 2022 and soared 518.89% in 2024, its largest moves.
- Tracing CRSP's Interest & Investment Income over 5 years: stood at $6.5 million in 2022, then soared by 33.04% to $8.6 million in 2023, then slumped by 199.87% to -$8.6 million in 2024, then soared by 98.08% to -$166000.0 in 2025, then slumped by 3954.22% to -$6.7 million in 2026.
- Business Quant data shows CRSP's Interest & Investment Income at -$6.7 million in Q1 2026, -$166000.0 in Q4 2025, and $973000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | CRISPR Therapeutics AG | 4.51 Bn | 4.51 Bn | - | -6.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.73 Mn |
| Dec 31, 2025 | -166,000.00 |
| Sep 30, 2025 | 973,000.00 |
| Jun 30, 2025 | -174,000.00 |
| Mar 31, 2025 | 2.25 Mn |
| Dec 31, 2024 | -8.64 Mn |
| Sep 30, 2024 | 13.37 Mn |
| Jun 30, 2024 | -1.33 Mn |
| Mar 31, 2024 | -3.45 Mn |
| Dec 31, 2023 | 8.65 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 452,000.00 |
| Mar 31, 2023 | 6.23 Mn |
| Dec 31, 2022 | 6.50 Mn |
| Sep 30, 2022 | -1.82 Mn |
| Jun 30, 2022 | -3.38 Mn |
| Mar 31, 2022 | -11.80 Mn |
| Dec 31, 2021 | -4.30 Mn |
| Sep 30, 2021 | -117,000.00 |
| Jun 30, 2021 | -173,000.00 |